MeiraGTx Holdings Plc (MGTX)
13.82
-0.32
(-2.26%)
USD |
NASDAQ |
Aug 28, 16:00
13.82
0.00 (0.00%)
Pre-Market: 20:00
MeiraGTx Holdings Enterprise Value : 1.271B for Aug. 28, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 28, 2026 | 1.271B |
| August 27, 2026 | 1.301B |
| August 26, 2026 | 1.341B |
| August 25, 2026 | 1.375B |
| August 24, 2026 | 1.366B |
| August 21, 2026 | 1.320B |
| August 20, 2026 | 1.339B |
| August 19, 2026 | 1.379B |
| August 18, 2026 | 1.278B |
| August 17, 2026 | 1.266B |
| August 14, 2026 | 1.243B |
| August 13, 2026 | 1.163B |
| August 12, 2026 | 1.190B |
| August 11, 2026 | 1.199B |
| August 10, 2026 | 1.196B |
| August 07, 2026 | 1.200B |
| August 06, 2026 | 1.174B |
| August 05, 2026 | 1.151B |
| August 04, 2026 | 1.127B |
| August 03, 2026 | 1.088B |
| July 31, 2026 | 1.080B |
| July 30, 2026 | 1.098B |
| July 29, 2026 | 1.064B |
| July 28, 2026 | 1.083B |
| July 27, 2026 | 1.128B |
| Date | Value |
|---|---|
| July 24, 2026 | 1.078B |
| July 23, 2026 | 1.109B |
| July 22, 2026 | 1.115B |
| July 21, 2026 | 1.149B |
| July 20, 2026 | 1.119B |
| July 17, 2026 | 1.141B |
| July 16, 2026 | 1.131B |
| July 15, 2026 | 1.152B |
| July 14, 2026 | 1.141B |
| July 13, 2026 | 1.132B |
| July 10, 2026 | 1.231B |
| July 09, 2026 | 1.282B |
| July 08, 2026 | 1.301B |
| July 07, 2026 | 1.350B |
| July 06, 2026 | 1.278B |
| July 02, 2026 | 1.280B |
| July 01, 2026 | 1.175B |
| June 30, 2026 | 1.242B |
| June 29, 2026 | 1.037B |
| June 26, 2026 | 1.002B |
| June 25, 2026 | 955.07M |
| June 24, 2026 | 960.77M |
| June 23, 2026 | 977.87M |
| June 22, 2026 | 950.99M |
| June 18, 2026 | 937.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xencor, Inc. | 1.651B |
| UroGen Pharma Ltd. | 2.219B |
| IDEAYA Biosciences, Inc. | 3.066B |
| ACADIA Pharmaceuticals, Inc. | 4.128B |
| Alnylam Pharmaceuticals, Inc. | 31.39B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 160.67M |
| Revenue (Quarterly) | 321.43M |
| Total Expenses (Quarterly) | 160.71M |
| EPS Diluted (Quarterly) | 1.713 |
| Gross Profit Margin (Quarterly) | 96.89% |
| Profit Margin (Quarterly) | 49.99% |
| Earnings Yield | 5.11% |
| Operating Earnings Yield | 15.68% |
| Normalized Earnings Yield | 5.019 |